Skip to main content
Equibles

MetLife Investment Management, LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1529735 Whippany, NJ
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$298,212
+$135,963 QoQ
Shares Held
20,609
+35.1% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 136 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. DSGN ranks #162 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in DSGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $298,212 20,609
2026-03-31 $162,249 15,249
2025-12-31 $143,035 15,249
2025-09-30 $77,709 10,320
2025-03-31 $73,193 18,962
2024-12-31 $119,290 19,334
2024-09-30 $104,016 19,334
2024-06-30 $0 0
2023-06-30 $138,883 22,045
2023-03-31 $127,199 22,045
2022-12-31 $226,181 22,045
2022-09-30 $368,592 22,045
2022-06-30 $236,390 16,885
2022-03-31 $272,692 16,885
2021-12-31 $232,598 10,864